Skip to main content

Peer Review reports

From: Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia

Original Submission
26 Apr 2018 Submitted Original manuscript
30 Oct 2018 Reviewed Reviewer Report - Hsin-An Hou
5 Jan 2019 Reviewed Reviewer Report - Eishi Ashihara
7 Jan 2019 Reviewed Reviewer Report - Reviewer 2
18 Jan 2019 Reviewed Reviewer Report - Paolo Gallipoli
24 Apr 2019 Author responded Author comments - Oliver Herrmann
Resubmission - Version 2
24 Apr 2019 Submitted Manuscript version 2
29 Apr 2019 Reviewed Reviewer Report - Eishi Ashihara
4 May 2019 Reviewed Reviewer Report - Paolo Gallipoli
30 May 2019 Reviewed Reviewer Report - Hsin-An Hou
12 Jun 2019 Author responded Author comments - Oliver Herrmann
Resubmission - Version 3
12 Jun 2019 Submitted Manuscript version 3
Publishing
24 Jun 2019 Editorially accepted
4 Jul 2019 Article published 10.1186/s12885-019-5871-2

You can find further information about peer review here.

Back to article page